Table 4 Results of estimated COI of prostate cancer (billion yen)
From: Cost of illness of the prostate cancer in Japan—a time-trend analysis and future projections
2002 | 2005 | 2008 | 2011 | Future estimates | |||||
|---|---|---|---|---|---|---|---|---|---|
2014 | 2017 | 2020 | |||||||
Direct cost | 97.0 | 164.2 | 195.9 | 219.4 | Fixed model | 240.4 | 250.6 | 268.1 | |
Linear model | 256.5 | 292.7 | 336.2 | ||||||
Logarithmic model | 239.7 | 248.0 | 258.6 | ||||||
Mixed model | 256.5 | 292.7 | 336.2 | ||||||
Inpatient care | 66.3 | 96.1 | 115.4 | 118.0 | Fixed model | 130.2 | 139.0 | 146.3 | |
Linear model | 118.8 | 135.1 | 153.6 | ||||||
Logarithmic model | 127.3 | 127.0 | 125.5 | ||||||
Mixed model | 118.8 | 135.1 | 153.6 | ||||||
Outpatient care | 30.7 | 68.1 | 80.5 | 101.4 | Fixed model | 110.2 | 111.6 | 121.9 | |
Linear model | 137.7 | 157.6 | 182.6 | ||||||
Logarithmic model | 112.4 | 121.4 | 133.1 | ||||||
Mixed model | 137.7 | 157.6 | 182.6 | ||||||
Mortality cost | 66.9 | 65.8 | 72.7 | 70.0 | Fixed model | 95.6 | 100.9 | 104.9 | |
Linear model | 96.6 | 100.2 | 105.9 | ||||||
Logarithmic model | 94.9 | 100.9 | 103.6 | ||||||
Mixed model | 79.5 | 81.6 | 83.6 | ||||||
Morbidity cost | 10.7 | 16.9 | 17.5 | 17.9 | Fixed model | 18.7 | 19.4 | 19.4 | |
Linear model | 25.2 | 28.2 | 31.9 | ||||||
Logarithmic model | 21.2 | 21.9 | 23.0 | ||||||
Mixed model | 26.0 | 28.7 | 32.1 | ||||||
COI | 174.5 | 246.9 | 286.0 | 307.3 | Fixed model | 354.7 | 370.9 | 392.4 | |
Linear model | 378.3 | 421.0 | 474.1 | ||||||
Logarithmic model | 355.8 | 370.8 | 385.3 | ||||||
Mixed model | 362.0 | 403.0 | 451.9 | ||||||